ArticleJournal of virology1997

Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.

S Ethelberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.